These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7866743)

  • 1. The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
    Champness JN; Achari A; Ballantine SP; Bryant PK; Delves CJ; Stammers DK
    Structure; 1994 Oct; 2(10):915-24. PubMed ID: 7866743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
    Cody V; Pace J; Chisum K; Rosowsky A
    Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
    Edman JC; Edman U; Cao M; Lundgren B; Kovacs JA; Santi DV
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8625-9. PubMed ID: 2682653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
    Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
    Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular model of the folate binding site of Pneumocystis carinii dihydrofolate reductase.
    Southerland WM
    J Comput Aided Mol Des; 1994 Apr; 8(2):113-22. PubMed ID: 8064329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based enzyme inhibitor design: modeling studies and crystal structure analysis of Pneumocystis carinii dihydrofolate reductase ternary complex with PT653 and NADPH.
    Cody V; Galitsky N; Luft JR; Pangborn W; Rosowsky A; Queener SF
    Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 Pt 2):946-54. PubMed ID: 12037296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
    Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
    Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.
    Cody V; Pace J; Namjoshi OA; Gangjee A
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):799-803. PubMed ID: 26057816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of a holoenzyme complex of mouse dihydrofolate reductase with NADPH and a ternary complex with the potent and selective inhibitor 2,4-diamino-6-(2'-hydroxydibenz[b,f]azepin-5-yl)methylpteridine.
    Cody V; Pace J; Rosowsky A
    Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):977-84. PubMed ID: 18703847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.
    Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A
    Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.
    Cody V; Luft JR; Pangborn W; Gangjee A; Queener SF
    Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):646-55. PubMed ID: 15039552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.
    Delves CJ; Ballantine SP; Tansik RL; Baccanari DP; Stammers DK
    Protein Expr Purif; 1993 Feb; 4(1):16-23. PubMed ID: 8425104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3092-6. PubMed ID: 11036028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasmid-encoded dihydrofolate reductase from trimethoprim-resistant bacteria has a novel D2-symmetric active site.
    Narayana N; Matthews DA; Howell EE; Nguyen-huu X
    Nat Struct Biol; 1995 Nov; 2(11):1018-25. PubMed ID: 7583655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase.
    Gschwend DA; Sirawaraporn W; Santi DV; Kuntz ID
    Proteins; 1997 Sep; 29(1):59-67. PubMed ID: 9294866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary crystallographic data for Pneumocystis carinii dihydrofolate reductase.
    Stammers DK; Delves C; Ballantine S; Jones EY; Stuart DI; Achari A; Bryant PK; Champness JN
    J Mol Biol; 1993 Mar; 230(2):679-80. PubMed ID: 8464076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of human enzyme.
    Stammers DK; Champness JN; Beddell CR; Dann JG; Eliopoulos E; Geddes AJ; Ogg D; North AC
    FEBS Lett; 1987 Jun; 218(1):178-84. PubMed ID: 3595861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase.
    Sirawaraporn W; Edman JC; Santi DV
    Protein Expr Purif; 1991; 2(5-6):313-6. PubMed ID: 1821803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.